Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients. Ikumi K, Torii K, Sagawa Y, Kanayama Y, et al. J Dermatol 2021 Dec 27. doi: 10.1111/1346-8138.16286.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ikumi K, Torii K, Sagawa Y, Kanayama Y, et al. Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients. J Dermatol 2021 Dec 27. doi: 10.1111/1346-8138.16286.
PMID: 34961971